PROFILE OF PEDIATRIC CHRONIC MYELOID LEUKEMIA IN THE ERA OF IMATINIB-A STUDY FROM A DEVELOPING COUNTRY

被引：0
|
作者：
Bernard, Catherene [1 ]
Rajendran, Rashmika [1 ]
Suman, Febe Renjitha [1 ]
Scott, Julius Xavier [1 ]
Rajendran, Aruna [1 ]
机构：
[1] Sri Ramachandra Med Coll & Res Inst, Madras, Tamil Nadu, India
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
514
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [41] Μultiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia
    A. Galanopoulos
    S. I. Papadhimitriou
    E. Kritikou-Griva
    M. Georgiakaki
    N. I. Anagnostopoulos
    Annals of Hematology, 2009, 88 : 281 - 282
  • [42] New indications - Gleevec - Imatinib - Novartis - Approved for pediatric chronic myeloid leukemia
    不详
    FORMULARY, 2003, 38 (07) : 398 - 398
  • [43] Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia
    Kovitz, Craig
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Abruzzo, Lynne V.
    Cortes, Jorge
    BLOOD, 2006, 108 (08) : 2811 - 2813
  • [44] Treatment of chronic myeloid Leukemia with Imatinib IRIS-Study
    Saussele, S.
    Nitschmann, S.
    INTERNIST, 2017, 58 (11): : 1220 - 1221
  • [45] Experience with biologic response modifiers in chronic myeloid leukemia in a developing country
    Babu, KG
    Bapsy, PP
    Lalitha, N
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 392 - 392
  • [46] Staging of chronic myeloid leukemia in the imatinib era - An evaluation of the World Health Organization proposal
    Cortes, JE
    Talpaz, M
    O'Brien, S
    Faderl, S
    Garcia-Manero, G
    Ferrajoli, A
    Verstovsek, S
    Rios, MB
    Shan, J
    Kantarjian, HM
    CANCER, 2006, 106 (06) : 1306 - 1315
  • [47] Are there new clinical parameters useful to predict response in chronic myeloid leukemia in the imatinib era?
    Breccia, Massimo
    Alimena, Giuliana
    LEUKEMIA RESEARCH, 2009, 33 (11) : 1450 - 1451
  • [48] The significance of early, major and stable molecular responses in chronic myeloid leukemia in the imatinib era
    Breccia, Massimo
    Alimena, Giuliana
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 79 (02) : 135 - 143
  • [49] Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience)
    Raihane Ben Lakhal
    Hela Ghedira
    Hatem Bellaaj
    Yosra Ben Youssef
    Samia Menif
    Zeineb Manai
    Manel Bedoui
    Amel Lakhal
    Fehmi M’Sadek
    Moez Elloumi
    Abderrahmane Khélif
    Neila Ben Romdhane
    Mohamed Adnène Laatiri
    Tarek Ben Othmen
    Balkis Meddeb
    Annals of Hematology, 2018, 97 : 597 - 604
  • [50] Follow up cytogenetic studies on a chronic myeloid leukemia case developing into acute myeloid leukemia after treatment with imatinib
    Kroes, Wilma
    Den Ouden, Elke
    Baasten, Mieke
    Buitenhuis, Corine
    Kerkhoffs, Jean-Louis
    Borne, Peter Von Dem
    MOLECULAR CYTOGENETICS, 2017, 10
12345